Status:
COMPLETED
Family Risk Analysis of Substance Use in Attention Deficit Hyperactivity Disorder (ADHD) Youth Treated With Concerta
Lead Sponsor:
Massachusetts General Hospital
Conditions:
ADHD
Smoking
Eligibility:
All Genders
6-55 years
Brief Summary
The researchers will study 100 families over three years, each with a child (proband) between the ages of 12-17, with the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)...
Detailed Description
As Attention Deficit Hyperactivity Disorder (ADHD) is a documented risk factor for smoking in adolescents, and as theoretical considerations suggest that ADHD and tobacco use may share common underlyi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- First-degree relative between the ages of 6-55 years of a family member (proband) between the ages of 12-17 with the DSM-IV diagnosis of ADHD
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00181792
Start Date
May 1 2005
End Date
August 1 2009
Last Update
May 4 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Cambridge, Massachusetts, United States, 02138